Affiliation:
1. 1 From the Department of Pediatrics, University of Pennsylvania and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, and the North American Trial Collaborators.
Abstract
Background.
It has been suggested that preterm infants may have developmental immaturity of the hypothalamic-pituitary-adrenal axis, and that decreased cortisol response to stress increases risk of chronic lung disease (CLD) secondary to inflammatory lung injury.
Methods.
To investigate the relationship between endogenous corticosteroid and CLD, we measured plasma cortisol during the first 28 days of life in a subset of neonates in the North American Thyrotropin-Releasing Hormone (TRH) Collaborative Trial. Analyses were performed on 314 infants, 24 to 32 weeks' gestation, whose mothers received 1 or 2 courses of antenatal corticosteroids plus TRH or placebo.
Results.
Mean cortisol was 3.1 μg/dL (range: 0.1–17.9) at birth, reached maximal levels at 24 hours (19.4 μg/dL, range: 0.8–124.6), and decreased to 5.9 μg/dL (range: 0.2–24.7) at 14 to 28 days of age; levels during the first week were not associated with gestational age. The Clinical Risk Index for Babies (CRIB), a neonatal assessment tool that is correlated with risk of mortality, was positively associated with cortisol level on days 1 and 3 through 7. TRH versus placebo treatment did not influence cortisol levels at any time point. To examine the relationship between cortisol and adverse outcome of death or CLD at 36 weeks' postmenstrual age (CLD36), logistic regression models adjusting for known contributing clinical factors (gestational age and CRIB score) were fit. There was a statistically borderline negative association between median cortisol level at 3 to 7 days and CLD36. After adjusting for gestational age and CRIB score, the predicted probability of CLD36 was only minimally influenced by the cortisol concentration.
Conclusion.
In preterm infants, basal plasma cortisol concentration during the first week is a weak predictor for CLD36. Possible benefits as well as risks of supplemental, low-dose cortisol treatment of high-risk preterm infants remain to be determined.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference24 articles.
1. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.;Groneck;Pediatrics,1994
2. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.;Pierce;Pediatr Pulmonol,1995
3. Serum adrenal steroid concentration in premature infants.;Lee;J Clin Endocrinol Metab,1989
4. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.;Watterberg;Pediatrics,1995
5. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in preterm infants.;Watterberg;Pediatrics,1999
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献